Sign in
4

Changes in Ownership

C4 Therapeutics, Inc. Filed Acc 0001662579-23-000045

Director acquired 3,516 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Anderson Kenneth Carl · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-04-03 Grant or award : show line 1 in the form +3,516 $3.20 $11,251 98,644 D
Loading xslF345X04/wf-form4_168063954562598.xml…